Juan Pablo Alderuccio, MD¹, Jahanzaib Khwaja², Sunwoo Han, PhD^3*, Paola Ghione, MD, MSEpi⁴, Imran A. Nizamuddin, MD⁵, Aditi Saha, MBBS⁶, Ning Dong, MD⁷, Yucai Wang, MD, PhD⁸, Hua-Jay J Cherng^9*, Seda S. Tolu, MD¹⁰, Nina D. Wagner-Johnston, MD¹¹, Adam J. Olszewski, MD¹², Natalie Grover, MD¹³, Jean L. Koff, MD, MSc¹⁴, Amrita Desai, MD, MPH¹⁵, Praveen Ramakrishnan Geethakumari, MD, MS¹⁶, Tamara K Moyo, MD^17*, Jose Sandoval-Sus, MD¹⁸, Narendranath Epperla, MD MS¹⁹, Danielle S Wallace, MD²⁰, Manali Kamdar, MD, MBBS^21*, Alexey Danilov, MD, PhD²², Han W. Tun, MD²³, Javier Munoz, MD^24*, Mayur S. Narkhede, MD²⁵, Joanna M. Rhodes, MD, MSCE^26*, Anca Prica, MD, MSc^27*, Andrea Kuhnl^28*, Adrian Maraj, FRCPath, MBBChir, MRCP^29*, Jessica Okosun, MB BChir PhD³⁰, Jeffery Smith, MBChB BMedSci MRCP FRCPath^31*, Wendy Osborne, MD^32*, Victoria Calvert^33*, Dima el-Sharkawi^34*, Ammar Hilali^35*, Graham P. Collins³⁶, Kim Linton^37*, Nagah Elmusharaf^38*, Anna Santarsieri, MBBS^39*, Farheen Karim^40*, Thomas Ollila, MD¹², Sarah Monick, MD^41*, Iris Margalit Trutzer, MD, PhD^42*, Nilanjan Ghosh^43*, Jones Can, MD^44*, Amy Ayers, MPH^14*, Jacopo Calabrese De Feo, MD^45*, John Sharp, MD⁴⁶, Rachel Treitman, BS^47*, Avyakta Kallam, MD^48*, Izel Okcu^8*, Vismay Deshani^49*, Firas Baidoun, MD^50*, Chathuri Abeyakoon^51*, William Hann^52*, Aisling Barrett, FRCPath, MB^53*, Brad Kahl, MD^54*, Julio C. Chavez, MD⁵⁵ and Kate Cwynarski, MBBS, PhD, FRCP, FRCPath^56*

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²University College London Hospitals NHS Foundation Trust, Sidcup, United Kingdom
³Biostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁶Department of Hematology/Oncology, Moffitt Cancer Center, West Orange, NJ
⁷H Lee Moffitt Cancer Center & Research Institute, Tampa
⁸Division of Hematology, Mayo Clinic, Rochester, MN
⁹Columbia University Irving Medical Center, New York, NY
¹⁰Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY
¹¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
¹²Brown University, Providence, RI
¹³University of North Carolina, Chapel Hill, NC
¹⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹⁵Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁶Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
¹⁷Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
¹⁸Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
¹⁹Ohio State University, Columbus, OH
²⁰Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
²¹Division of Hematology, Hematologic Malignancies and Stem Cell Transplant, University of Colorado Cancer Center, Aurora, CO
²²City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA
²³Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
²⁴Mayo Clinic, Phoenix, AZ
²⁵Department of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL
²⁶Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²⁸King's College Hospital NHS Foundation Trust, London, United Kingdom
²⁹St James Hospital, Dublin, Ireland
³⁰Department of Haemato-Oncology, Barts Hospital, London, ENG, United Kingdom
³¹The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
³²Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom
³³Freeman Hospital, Newcastle University, Newcastle, United Kingdom
³⁴The Royal Marsden NHS Foundation Trust, London, United Kingdom
³⁵Royal Marsden NHS Foundation Trust, London, United Kingdom
³⁶Oxford Cancer and Haematology Centre, Oxford, United Kingdom
³⁷The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
³⁸University Hospital of Wales, Cardiff, United Kingdom
³⁹Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom
⁴⁰The Royal Wolverhampton NHS Trust, Wolverhampton, GBR
⁴¹Mayo Clinic Arizona, Phoenix
⁴²The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
⁴³Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴⁴Moffitt Malignant Hematology at Memorial Healthcare System, Pembroke Pines
⁴⁵Memorial Sloan Kettering Cancer Center, New York City
⁴⁶James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁴⁷University of Colorado School of Medicine, Denver, CO
⁴⁸City of Hope National Medical Center, Duarte, CA
⁴⁹The Christie NHS Foundation Trust, Manchester, United Kingdom
⁵⁰Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁵¹Princess Margaret Cancer Centre, Toronto, Canada
⁵²Barts Cancer Institute, London, United Kingdom
⁵³Oxford University Hospital, Oxford, ENG, GBR
⁵⁴Washington University Medical School, St Louis, MO
⁵⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵⁶University College London, London, United Kingdom

Motoo Nagane^1*, Manabu Natsumeda, MD, PhD^2,3*, Fumiharu Ohka, MD, PhD^4*, Fumiyuki Yamasaki, MD, PhD^5*, Hajime Yonezawa, MD, PhD^6*, Nobuyoshi Sasaki^7*, Shigeru Yamaguchi, MD, PhD^8*, Kensuke Tateishi, MD, PhD^9*, Yoshitaka Narita, MD, PhD^10*, Yasukazu Kawai, MD, PhD^11*, Hiroyuki Sugahara, MD, PhD^12*, Jyunichiro Kuroda, MD, PhD^13*, Takeshi Okuda, MD, PhD^14*, Tomoo Matsutani, MD, PhD^15*, Manabu Kinoshita, MD, PhD^16*, Naoto Tomita, MD, PhD¹⁷, Keiichiro Hattori, MD, PhD^18*, Jun Muto, MD, PhD^19*, Noriaki Kitamura, MD^20*, Keita Kinoshita, PhD^21* and Kazuhiko Mishima, MD, PhD^22*

¹Department of Neurosurgery, Kyorin University Faculty of Medicine, Mitaka, Tokyo, Japan
²Advanced Treatment of Neurological Diseases Branch, Brain Research Institute, Niigata University, Niigata, Japan
³Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
⁴Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
⁵Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
⁶Department of Neurosurgery, Kagoshima University Hospital, Kagoshima, Japan
⁷Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan
⁸Departments of Neurosurgery, Faculty of Medicine, Hokkaido University, Sapporo, Japan
⁹Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
¹⁰Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan
¹¹Department of Hematology and Oncology, Fukui Prefectural Hospital, Fukui, Japan
¹²Department of Hematology, Sumitomo Hospital, Osaka, Japan
¹³Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
¹⁴Department of Neurosurgery, Kindai University Faculty of Medicine, Osaka, Japan
¹⁵Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
¹⁶Department of Neurosurgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
¹⁷Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan
¹⁸Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
¹⁹Department of Neurosurgery, Fujita Health University, Aichi, Japan
²⁰Department of Hematology, University of Occupational and Environmental Health, Kitakyushu, Japan
²¹Oncology Medical Affairs, Ono Pharmaceutical Co., Ltd., Osaka, Japan
²²Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan

Matthew Hamby, BSc¹, Brian Egleston, PhD^2*, Zachary AK Frosch, MD, MSHP³, Raphael E. Steiner, MD⁴, Ariela Noy, MD⁴, Veronica Carvajal, BS^5*, Seda S. Tolu, MD⁶, Gaston Jean-Louis, MD^7*, Jennifer E. Amengual, MD⁸, Romil Patel, MD⁹, Sairah Ahmed, MD^9,10,11, Timothy Voorhees, MD, MSc¹², Robert Baiocchi, MD, PhD¹³, Andres Ramirez-Gamero, MD^14*, Jorge J. Castillo, MD^14,15, Emily Hamburger, MD^16*, Christopher Dittus, DO¹⁶, Imran A. Nizamuddin, MD¹⁷, Neha Mehta-Shah, MD^18,19, Nyein Nyein Thaw Dar, MBBS, MSc^20*, Jose Sandoval-Sus, MD²¹, Alexandra E. Rojek, MD²², Peter A. Riedell, MD²², Vinod Solipuram, MD^23*, Paul G. Rubinstein, MD²⁴, Anthony Ariotti^25*, Gita Suneja, MD, MS^25*, Alexander Vartanov, MD²⁶, Charles Milrod, MD²⁷, Adam J. Olszewski, MD²⁸, Gordon Smilnak, MD^29*, Emily Ayers, MD²⁹, Sahaj Desai, MD^30*, Joanna M. Rhodes, MD³⁰, Gabriella Magarelli, MSN, ACNP-BC, AOCNP^31*, Tatyana Feldman, MD³², Meredith Pellon^33*, David M. Aboulafia, MD^34*, William Bae, MD³⁵, Carlos Galvez, MD³⁵, Vineel Bhatlapenumarthi, MD^36*, Mehdi Hamadani, MD³⁷ and Stefan K. Barta, MD^38,39

¹University of Pennsylvania, Lancaster, PA
²Fox Chase Cancer Center, Philadelphia, PA
³Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
⁶Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY
⁷Columbia University, New York, NY
⁸Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹MD Anderson Cancer Center, Houston, TX
¹²Division of Hematology, The Ohio State University, Columbus, OH
¹³James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹⁴Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
¹⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁶Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
¹⁷Division of Oncology, Washington University School of Medicine, St. Louis, MO
¹⁸Siteman Cancer Center, Washington University in St. Louis, St Louis, MO
¹⁹Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
²⁰Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
²¹Department of Malignant Hematology and Cellular Therapy, Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
²²Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²³John H. Stroger Jr. Hospital of Cook County, Chicago
²⁴John Stroger Cook County Hospital, Chicago, IL
²⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁶Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
²⁷Department of Hematology/Oncology, Brown University, Providence, RI
²⁸Brown University, Providence, RI
²⁹University of Virginia, Charlottesville, VA
³⁰Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³²Hackensack Meridian Health Hackensack University Medical Center, NY, NY
³³Virginia Mason Medical Center, Seattle, WA
³⁴Virginia Mason Clinic, Seattle, WA
³⁵Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
³⁶Department of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI
³⁷Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³⁸Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA
³⁹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Jiayu Yang, MD¹, Anna R. Hayden, MD¹, Diego Villa, MD^1,2, Aixiang Jiang, MS^3*, Alina S. Gerrie, MD, MPH^1,3, Christopher P. Venner, MD^1,3, Pedro Farinha^3,4, David W. Scott, MBChB, PhD^1,3, Laurie H. H. Sehn, MD^1,3 and Kerry J. Savage, MD, MSc^1,3

¹Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
²Centre for Lymphoid Cancer, BC Cancer – Vancouver Cancer Centre, Vancouver, BC, Canada
³Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁴Department of Pathology, University of British Columbia, Vancouver, BC, Canada

Vincent Camus, MD, PhD^1,2*, Thierry Jo Molina, MD, PhD^3*, Fabienne Desmots-Loyer, PhD^4*, Amine Moslemi, MD^5*, Philippe Ruminy, PhD^2*, Steven Le Gouill, MD, PhD⁶, Herve Ghesquieres, MD, PhD^7*, Lucie Oberic, MD^8*, Franck Morschhauser⁹, Hervé Tilly², Vincent Ribrag, MD¹⁰, Roch Houot, MD, PhD^11*, Catherine Thieblemont, MD¹², Herve Maisonneuve, MD^13*, Fabien Claves, MD^14*, Krimo Bouabdallah, MD^15*, Corinne Haioun, MD, PhD¹⁶, Gandhi Damaj, MD, PhD^17*, Luc-Matthieu Fornecker, MD, PhD^18*, Robin Noel, MD^19*, Pierre Feugier, MD, PhD^20*, David Sibon, MD, PhD^21*, Guillaume Cartron, MD, PhD^22,23*, Christophe Bonnet, MD, PhD^24*, Marc André, MD, PhD^25*, Françoise Kraeber-Bodéré, MD, PhD^26,27*, Caroline Milin, MD, PhD^26,27*, Jean-Philippe Jais, MD, PhD^28*, Josette Briere, MD^29*, Olivier Casasnovas, MD^30,31*, Salim Kanoun, MD^32,33*, Emmanuel Itti, MD, PhD^34*, Paul Blanc-Durand^35*, Mad-Hélénie Elsensohn^36*, Loic Chartier^37*, Fabrice Jardin, MD, PhD^2* and Thierry Fest, MD, PhD^38,39*

¹Centre Henri Becquerel, Department of Hematology, Rouen, France
²INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
³Department of Pathology, Assistance Publique-Hôpitaux de Paris, Necker and Robert Debré Hospital, Université Paris Cité, Paris, France
⁴Laboratoire d'Hématologie, Université de Rennes 1, INSERM, Établissement Français du Sang de Bretagne, Team B_DEVIL, UMR_S1236, Rennes, France; Centre Hospitalier Universitaire, RENNES, France
⁵Department of Pathology, Amiens University Hospital, Amiens, FRA
⁶Institut Curie, Saint-Cloud, France
⁷Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
⁸IUCT - Oncopole, Hematology Department, Toulouse, France
⁹Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
¹⁰Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
¹¹Hematology department, CHU Rennes - Hopital Pontchaillou, Rennes, France
¹²Hospital Saint-Louis, Paris, France
¹³Centre Hospitalier Departemental de Vendée, La Roche-sur-Yon, FRA
¹⁴Department of Hematology, University Hospital Grenoble - HOPITAL ALBERT MICHALLON, Grenoble, France
¹⁵Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
¹⁶Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
¹⁷CHU Caen, Caen, Normandy, FRA
¹⁸Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
¹⁹Institut Paoli-Calmettes, Marseille, FRA
²⁰CHU Brabois - Service d'Hématologie - Université Henri Poincaré, Nancy, France
²¹Lymphoid Hematology Department, Henri Mondor University Hospital, AP-HP, Paris, France
²²Centre Hospitalier Universitaire de Montpellier, Montpellier, France
²³Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France
²⁴Hématologie clinique, CHU de Liège, Université de Liège, Liège, Belgium
²⁵CHU UCL Namur, Yvoir, Belgium
²⁶CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
²⁷Department of Nuclear Medicine, University Hospital of Nantes, Nantes, France
²⁸Hôpital Necker-Enfants Malades, PARIS, France
²⁹University Hospital Henri-Mondor, APHP, INSERM U955, Créteil, FRA
³⁰François Mitterand Hospital, Dijon, FRA
³¹INSERM 1231, Dijon, France
³²Pixilib SAS, ; Centre de Recherche Clinique de Toulouse, Team 9 INSERM Unité Mixte de Recherche 1037, Toulouse, France
³³Nucear Medicine Department, IUCT Oncopole, Toulouse, France
³⁴Nuclear medicine department, Henri Mondor University Hospital, AP-HP, Créteil, FRA
³⁵CHU Henri Mondor, Creteil, FRA
³⁶Lymphoma Academic Research Organization (LYSARC), Lyon, France
³⁷Department of Biostatistics, Lymphoma Academic Research Organization (LYSARC), Lyon, France
³⁸Inserm, Université de Rennes 1, Rennes, France
³⁹Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, INSERM, Établissement Français du Sang de Bretagne, Team B_DEVIL, UMR_S1236, Rennes, France

Jinhua Liang, PhD^1*, Yi-fan Wu, MD^2*, Jun-heng Liang, MD^3*, Yue Li^2*, Xin-Yu Zhang, MD, PhD^2*, Hao-Rui Shen^2*, Jiazhu Wu^4*, Liu qing Zhu, MD, PhD^3*, Hua Yin^4*, Li Wang^4*, Jianyong Li, MD⁵ and Xu Wei, MD, PhD⁴

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, NANJING, China
²Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Nanjing Geneseeq Technology Inc., Nanjing, China
⁴Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁵First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China